A Systematic Review and Bayesian Network Meta-Analysis on the Effect of Different Anticoagulants on the Prophylaxis of Post-Thrombotic Syndrome after Deep …
J Shao, Q Zhou, F Jin, C Reissfelder, M Sigl… - Journal of Clinical …, 2023 - mdpi.com
Background: Postthrombotic syndrome (PTS) has a major impact on the quality of life after
deep venous thrombosis (DVT). From clinical practice and related trials, anticoagulants …
deep venous thrombosis (DVT). From clinical practice and related trials, anticoagulants …
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: a real …
XL Marston, R Wang, YC Yeh, L Zimmermann… - International journal of …, 2022 - Elsevier
Background The aim of the study was to compare the real-world effectiveness and safety in
atrial fibrillation (AF) patients treated with edoxaban versus other oral anticoagulants …
atrial fibrillation (AF) patients treated with edoxaban versus other oral anticoagulants …
Edoxaban in cardiovascular disease management
S Srinivasan, M Ajmal, C Pecci… - British Journal of Clinical …, 2022 - Wiley Online Library
In the past decade, direct oral anticoagulants (DOACs) have transformed the world of anti‐
thrombotic therapy. Edoxaban is the most recently approved DOAC. Though intended for …
thrombotic therapy. Edoxaban is the most recently approved DOAC. Though intended for …